Suppr超能文献

患有慢性肺病的婴儿因呼吸道合胞病毒(RSV)感染住院的医疗服务利用情况。

Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection.

作者信息

Greenough A, Cox S, Alexander J, Lenney W, Turnbull F, Burgess S, Chetcuti P A, Shaw N J, Woods A, Boorman J, Coles S, Turner J

机构信息

Dept of Child Health, King's College Hospital, London SE5 9RS, UK.

出版信息

Arch Dis Child. 2001 Dec;85(6):463-8. doi: 10.1136/adc.85.6.463.

Abstract

AIMS

To compare the use of health care resources and associated costs between infants with chronic lung disease (CLD) who had or had not an admission with a proven respiratory syncytial virus (RSV) infection.

METHODS

Review of community care, outpatient attendances, and readmissions in the first two years after birth.

PATIENTS

235 infants (median gestational age 27 weeks) evaluated in four groups: 45 infants with a proven RSV admission (RSV proven); 24 with a probable bronchiolitis admission; 60 with other respiratory admissions; and 106 with non-respiratory or no admissions.

RESULTS

The RSV proven compared to the other groups required more frequent and longer admissions to general paediatric wards and intensive care units, more outpatient attendances and GP consultations for respiratory related disorders, and had a higher total cost of care.

CONCLUSION

RSV hospitalisation in patients with CLD is associated with increased health service utilisation and costs in the first two years after birth.

摘要

目的

比较患有慢性肺病(CLD)且有或没有确诊为呼吸道合胞病毒(RSV)感染入院史的婴儿之间医疗资源的使用情况及相关费用。

方法

回顾出生后头两年的社区护理、门诊就诊及再次入院情况。

患者

235名婴儿(中位胎龄27周)分为四组进行评估:45名确诊为RSV感染入院的婴儿(确诊RSV);24名可能因细支气管炎入院的婴儿;60名因其他呼吸道疾病入院的婴儿;106名非呼吸道疾病或未入院的婴儿。

结果

与其他组相比,确诊RSV的婴儿需要更频繁、更长时间地入住普通儿科病房和重症监护病房,因呼吸道相关疾病进行更多的门诊就诊和全科医生会诊,且护理总费用更高。

结论

CLD患者的RSV住院治疗与出生后头两年医疗服务利用率增加及费用增加有关。

相似文献

3
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.
4
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54. doi: 10.1097/01.inf.0000053885.34703.84.
5
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.
Public Health. 2024 Feb;227:103-111. doi: 10.1016/j.puhe.2023.11.039. Epub 2023 Dec 27.
6
School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants.
Thorax. 2009 Jun;64(6):490-5. doi: 10.1136/thx.2008.095547. Epub 2009 Feb 12.
9
RSV hospitalisation and healthcare utilisation in moderately prematurely born infants.
Eur J Pediatr. 2012 Jul;171(7):1055-61. doi: 10.1007/s00431-012-1673-0.

引用本文的文献

4
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
6
RSV disease in infants and young children: Can we see a brighter future?
Hum Vaccin Immunother. 2022 Nov 30;18(4):2079322. doi: 10.1080/21645515.2022.2079322. Epub 2022 Jun 20.
7
An Update on the Prevention and Management of Bronchopulmonary Dysplasia.
Pediatric Health Med Ther. 2021 Aug 11;12:405-419. doi: 10.2147/PHMT.S287693. eCollection 2021.
8
Systematic review of the healthcare cost of bronchopulmonary dysplasia.
BMJ Open. 2021 Aug 10;11(8):e045729. doi: 10.1136/bmjopen-2020-045729.
9
Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease.
Front Med (Lausanne). 2021 May 31;8:665152. doi: 10.3389/fmed.2021.665152. eCollection 2021.
10
Transcutaneous carbon dioxide pattern and trend over time in preterm infants.
Pediatr Res. 2021 Oct;90(4):840-846. doi: 10.1038/s41390-020-01308-2. Epub 2021 Jan 19.

本文引用的文献

1
Preventing respiratory syncitial virus bronchiolitis.
BMJ. 2001 Jan 13;322(7278):62-63. doi: 10.1136/bmj.322.7278.62.
2
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.
J Pediatr. 2000 Dec;137(6):865-70. doi: 10.1067/mpd.2000.110531.
5
Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.
Am J Respir Crit Care Med. 2000 May;161(5):1501-7. doi: 10.1164/ajrccm.161.5.9906076.
6
Advances in prevention of respiratory syncytial virus infections.
J Pediatr. 1999 Nov;135(5):546-58. doi: 10.1016/s0022-3476(99)70051-x.
7
Rehospitalization for respiratory syncytial virus among premature infants.
Pediatrics. 1999 Oct;104(4 Pt 1):894-9. doi: 10.1542/peds.104.4.894.
8
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.
Lancet. 1999 Aug 14;354(9178):541-5. doi: 10.1016/S0140-6736(98)10321-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验